The Study of Heamostatic Function in Patients with Gastrointestinal Cancer in Relapse or Metastasis
Li-fang ZOU,Yi-yun YAO,Hong-Ju DOU,Qi ZHU,Jun-pei HU
DOI: https://doi.org/10.3969/j.issn.1009-6213.2011.05.007
2011-01-01
Abstract:Objective To investigate the haemostatic changes of patients with gastrointestinal cancer at the different stages,such as disease in relapse or metastasis.Methods Routine haemostatic tests were conducted among 42 patients with gastrointestinal cancer.30 healthy volunteers were enrolled as controls.The tests included the plasma concentration of PLT,PT,aPTT,TT,Fbg.Some coagulable and fibrinolytic molecular markers,such as GMP-140,TF,TAT,TFPI,TpP,PAP,u-PA,t-PA,PAI-1 were also measured.The activities of coagulation factors Ⅱ,Ⅴ,Ⅶ,Ⅷ,Ⅸ,Ⅹ,Ⅺ and AT were evaluated as well.Results ① The plasma of Fbg were elevated in gastrointestinal cancer patients(P<0.05),while in relapse and metastasis groups,the levels were significantly higher than that of the control(P<0.01).At the same time,PT and aPTT were shortened(P<0.05).② The plasma levels of GMP-140,TF,TAT and TpP were elevated in gastrointestinal cancer patients(P<0.05).In the meanwhile,the levels significantly higher than that of the control(P<0.05 or P<0.01) in the relapse and metastasis groups,Increased activity of coagulation factors Ⅶ,X and decreased activity of AT also took place at the same time(P<0.05).③ Compared with the normal control,the patients with gastrointestinal cancer had higher concentrations of fibrinolytic parameters,such as PAP,u-PA,t-PA and D-dimer(P<0.05).While in the relapse and metastasis,all these parameters raised more remarkably(P<0.05 or P<0.01).Furthermore,the concentration of fibrinogen inhibitor PAI-1 was also elevated(P<0.05).Conclusion Patients with gastrointestinal cancer may harbor platelet aggregation,activation of coagulation cascade,decreased synthesis of anticoagulant proteins and abnormal activation of fibrinolysis.In the group of the patients with gastrointestinal cancer,the plasma levels of Fbg plays an important role in predicting the relapse and metastasis of the disease.Other changes of routine results seems to have no definite impact on the progress of disease.Variable levels of the molecular markers of platelet activation、coagulable and fibrinolitic system changed remarkably in patients with relapse and metastasis.Therefore,these markers could be considered as sensitive predicators of progress.